Guidelines for the Management of Patients with Chronic Stable Angina
Authors: Geoffrey A. Modest
Journal: Annals of Internal Medicine (2002)

Letters17 September 2002Guidelines for the Management of Patients with Chronic Stable AnginaGeoffrey A. Modest, MDGeoffrey A. Modest, MDUpham's Corner Health Center; Dorchester, MA 02125Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-6-200209170-00028 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The guidelines for management of patients with chronic stable angina (1) represent an update from leading cardiology associations. Overall, the publication of these types of guidelines is useful for developing uniformity of practice when there is clear consensus due to high-quality, evidence-based clinical studies. The current applicability of such evidence, however, is often questioned. In particular, in these guidelines, the recommendations for revascularization in patients with left main, three-vessel disease, or two-vessel disease with involvement of the proximal left anterior descending artery are considered class I (evidence that treatment is useful) and grade A (high-quality data based ...References1. Fihn SD, Williams SV, Daley J, Gibbons RJ. Guidelines for the management of patients with chronic stable angina: treatment. Ann Intern Med. 2001;135:616-32. [PMID: 11601935] LinkGoogle Scholar2. Davies RF, Goldberg AD, Forman S, Pepine CJ, Knatterud GL, Geller N, et al . Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997;95:2037-43. [PMID: 9133513] CrossrefMedlineGoogle Scholar3. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, et al . Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70-6. [PMID: 10395630] CrossrefMedlineGoogle Scholar4. . Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients. Am J Cardiol. 1993;72:1031-7. [PMID: 8213583] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Upham's Corner Health Center; Dorchester, MA 02125 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoGuidelines for the Management of Patients with Chronic Stable Angina: Treatment Stephan D. Fihn , Sankey V. Williams , Jennifer Daley , and Raymond J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina: Treatment Stephan D. Fihn , Sankey V. Williams , Jennifer Daley , and Raymond J. Gibbons Guidelines for the Management of Patients with Chronic Stable Angina Stephan D. Fihn , Sankey V. Williams , and Raymond J. Gibbons Metrics Cited ByEffect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention 17 September 2002Volume 137, Issue 6Page: 548-549KeywordsAnginaAngioplastyLipidsMedical risk factorsNitratesRevascularizationStable coronary artery diseaseSurgeryTreatment guidelines ePublished: 17 September 2002 Issue Published: 17 September 2002 CopyrightCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...